Takip et
Michele Mario Reni
Michele Mario Reni
IRCCS San Raffaele
hsr.it üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
DD Von Hoff, T Ervin, FP Arena, EG Chiorean, J Infante, M Moore, T Seay, ...
New England Journal of Medicine 369 (18), 1691-1703, 2013
65572013
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ...
New England Journal of Medicine 381 (4), 317-327, 2019
18902019
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience
AJ Ferreri, JY Blay, M Reni, F Pasini, M Spina, A Ambrosetti, A Calderoni, ...
Journal of Clinical Oncology 21, 266-272, 2003
8902003
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
AJM Ferreri, M Reni, M Foppoli, M Martelli, GA Pangalis, M Frezzato, ...
The Lancet 374 (9700), 1512-1520, 2009
753*2009
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
L De Monte, M Reni, E Tassi, D Clavenna, I Papa, H Recalde, M Braga, ...
Journal of Experimental Medicine 208 (3), 469-478, 2011
7222011
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ...
J Clin Oncol 24 (16), 2563-2569, 2006
6242006
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the …
AJM Ferreri, K Cwynarski, E Pulczynski, M Ponzoni, M Deckert, LS Politi, ...
The Lancet Haematology 3 (5), e217-e227, 2016
5232016
Meningioma
C Marosi, M Hassler, K Roessler, M Reni, M Sant, E Mazza, C Vecht
Critical reviews in oncology/hematology 67 (2), 153-171, 2008
5022008
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ...
The Lancet Oncology 17 (11), 1521-1532, 2016
4842016
A multicenter study of treatment of primary CNS lymphoma
AJM Ferreri, M Reni, F Pasini, A Calderoni, U Tirelli, A Pivnik, GM Aondio, ...
Neurology 58 (10), 1513-1520, 2002
4362002
Intra-and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning
C Fiorino, M Reni, A Bolognesi, GM Cattaneo, R Calandrino
Radiotherapy and oncology 47 (3), 285-292, 1998
4211998
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
M Reni, S Cordio, C Milandri, P Passoni, E Bonetto, C Oliani, G Luppi, ...
The lancet oncology 6 (6), 369-376, 2005
3362005
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS …
AJM Ferreri, K Cwynarski, E Pulczynski, CP Fox, E Schorb, P La Rosée, ...
The Lancet Haematology 4 (11), e510-e523, 2017
3012017
Glioblastoma in adults
AA Brandes, A Tosoni, E Franceschi, M Reni, G Gatta, C Vecht
Critical reviews in oncology/hematology 67 (2), 139-152, 2008
2622008
Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature
M Reni, AJM Ferreri, MP Garancini, E Villa
Annals of Oncology 8 (3), 227-234, 1997
2411997
Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent …
AA Brandes, A Tosoni, G Cavallo, M Reni, E Franceschi, L Bonaldi, ...
Journal of clinical oncology 24 (29), 4746-4753, 2006
2202006
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial
M Reni, G Balzano, S Zanon, A Zerbi, L Rimassa, R Castoldi, D Pinelli, ...
The lancet Gastroenterology & hepatology 3 (6), 413-423, 2018
2152018
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.
GL Ceresoli, M Reni, G Chiesa, A Carretta, S Schipani, P Passoni, ...
Cancer 95 (3), 605-612, 2002
2092002
Ependymoma
M Reni, G Gatta, E Mazza, C Vecht
Critical reviews in oncology/hematology 63 (1), 81-89, 2007
1972007
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma
F Marchesi, L Piemonti, G Fedele, A Destro, M Roncalli, L Albarello, ...
Cancer research 68 (21), 9060-9069, 2008
1942008
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20